​

Cognition Therapeutics (CGTX) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

CGTX Stock Rating

Cognition Therapeutics stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (80.00%), 1 Hold (20.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 1 4 Strong Sell Sell Hold Buy Strong Buy

CGTX Price Target Upside V Benchmarks

TypeNameUpside
StockCognition Therapeutics-
SectorHealthcare Stocks 25.19%
IndustryBiotech Stocks 61.26%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.63$0.63$0.63
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 2514---5
Jan, 2514---5
Dec, 24141--6
Nov, 24131--5
Oct, 24132--6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 19, 2024B. RileyNeutralBuyupgrade
Dec 19, 2024H.C. WainwrightBuyBuyhold
Nov 04, 2024H.C. WainwrightBuyBuyhold
Aug 06, 2024B. RileyNeutraldowngrade
Jul 29, 2024Cantor FitzgeraldNeutraldowngrade
Jun 06, 2024Chardan CapitalBuyinitialise
May 29, 2024H.C. WainwrightBuyinitialise
Apr 16, 2024OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.86-----
Avg Forecast$-0.93$-0.82$-0.61$-0.57$-0.57$-0.68
High Forecast$-0.86$-0.64$-0.29$-0.57$-0.57$-0.68
Low Forecast$-0.99$-0.89$-0.88$-0.57$-0.57$-0.68
Surprise %-7.53%-----

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast----$41.93M$143.82M
High Forecast----$41.93M$143.82M
Low Forecast----$41.93M$143.82M
Surprise %------

Net Income Forecast

$-30M $-25M $-20M $-15M $-10M $-5M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-25.79M-----
Avg Forecast$-25.79M$-22.98M$-17.49M$-17.12M$-17.12M$-20.42M
High Forecast$-25.78M$-19.12M$-8.60M$-17.12M$-17.12M$-20.42M
Low Forecast$-29.63M$-26.83M$-26.37M$-17.12M$-17.12M$-20.42M
Surprise %------

CGTX Forecast FAQ

Is Cognition Therapeutics stock a buy?

Cognition Therapeutics stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Cognition Therapeutics is a favorable investment for most analysts.

What is Cognition Therapeutics's price target?

Cognition Therapeutics's price target, set by 5 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $0.63.

How does Cognition Therapeutics stock forecast compare to its benchmarks?

Cognition Therapeutics's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (25.19%) and underperforming the biotech stocks industry (61.26%).

What is the breakdown of analyst ratings for Cognition Therapeutics over the past three months?

  • February 2025: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 16.67% Strong Buy, 66.67% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.

What is Cognition Therapeutics’s EPS forecast?

Cognition Therapeutics's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.82, marking a -4.65% decrease from the reported $-0.86 in 2023. Estimates for the following years are $-0.61 in 2025, $-0.57 in 2026, $-0.57 in 2027, and $-0.68 in 2028.

What is Cognition Therapeutics’s revenue forecast?

Cognition Therapeutics's average annual revenue forecast for its fiscal year ending in December 2024 is $0, reflecting a 0% decrease from the reported $0 in 2023. The forecast for 2025 is $0, followed by $0 for 2026, $41.93M for 2027, and $143.82M for 2028.

What is Cognition Therapeutics’s net income forecast?

Cognition Therapeutics's net income forecast for the fiscal year ending in December 2024 stands at $-22.978M, representing a -10.90% decrease from the reported $-25.788M in 2023. Projections indicate $-17.485M in 2025, $-17.117M in 2026, $-17.117M in 2027, and $-20.42M in 2028.